TIME | TOPIC | SPEAKER |
---|
6:45 am - 7:45 pm | Satellite #1: Topic TBD | Cytokinetics |
7:45 am - 8:00 am | Coffee Break | |
8:00 am - 8:15 am | Opening Remarks | |
8:15 am - 9:15 am | Session 1: Multimodality Imaging for Diagnosis, Risk Stratification and Management of Hypertrophic Cardiomyopathy | Moderators: Jeffrey Geske, Martin Maron |
| New perspectives on diagnosis and differential diagnosis of HCM: Artificial intelligence to the rescue? | James Moon |
| Unmasking a masquerader: leveraging multimodality imaging to characterize phenocopies | Ahmad Masri |
| Sudden death risk assessment and multimodality imaging: Reconciling recommendations across the pond | Betty Raman |
| The good the bad the ugly of imaging a CMI patient | Milind Desai |
| Moderated discussion | All |
9:15 am - 9:30 am | Break | |
9:30 am - 10:30 am | Session 2: Impact of Genetics on the Family – from Mendelian to Polygenic | Moderators: Sharon Cresci, Michele Michels |
| How has the bench helped us be better at the bedside? | Jolanda Van der Velden |
| The basics of pediatric HCM: Who, what, when, where, why? | Joe Rossano |
| Emerging concepts in genetic testing: The new ground truth or still works in progress? | Jodie Ingles |
| Leveraging polygenic risk scores in HCM: Is more the merrier? | James Ware |
| Moderated discussion | All |
10:30 am - 11:00 am | The Inaugural Eugene Braunwald Lecture | Watch for the announcement soon! |
11:00 am - 12:30 am | Lunch - visit with sponsors | |
11:30 am - 12:30 pm | Satellite #2: Topic TBD | BMS |
12:30 pm - 12:45 pm | Break | |
12:45 pm - 2:25 pm | Session 3: Approved and Novel Therapies for the Management of Obstructive and Nonobstructive HCM | Moderators: Sharlene Day, Andrew Wang, |
| More (Aerobic) Power to the People | James Macnamara |
| CMIs in Obstructive HCM: Exploring Sequoia trees with Valor while enjoying Maple syrup | Sara Saberi |
| Treatment of nonobstructive HCM: Where are we? And where do we go? | Anjali Owens |
| Invasive Therapies for Obstructive HCM : A shave, a tuck or a squirt ? | Nick Smedira |
| (Debate) What path for which patient: CMI vs. SRT as an initial option | Matthew Martinez, Steve Ommen, Andrew Wang |
| (Panel Discussion) HCM is a Team Sport | Jane Linderbaum; Ted Abraham; Erin Davidson, PharmD; Alex de Feria; Susan Ospina, NP; Ozlam Bilen |
2:25 pm - 2:40 pm | Break | |
2:40 pm - 3:40 pm | Oral Abstracts with moderated discussion (watch for announcements!) | Moderators Carolyn Ho, Nosheen Reza |
3:45 pm - 4:45 pm | Session 4: Complications of Hypertrophic Cardiomyopathy: Recognition and Treatment of Arrhythmias and Advanced Heart Failure | Moderators Mariko Harper, Anna Woo |
| Rowin' Troubled Rivers: AF in HCM is a bad actor | Ethan Rowin |
| Afib and VT management in the eyes of EP: Monitor, medicate, anticoagulate, and ablate | Fatima Ezzeddine |
| Navigating the bridge too far: Advanced heart failure and transplantation | Jorge Silva Enciso |
| ICD selection: the right wire for the right warrior | Mark Link |
| Moderated discussion | All |
4:45 pm - 5:45 pm | Session 5: Managing Double Trouble - How the Experts Approach Complex Cases | Moderators Richard Bach, Melissa Burroughs |
| Severe aortic stenosis and obstructive HCM | Srihari Naidu |
| Severe oHCM and severe CAD: Navigating complex LGE pattern | Albree Tower Radar |
| Amyloid and HCM | Florian Rader |
| Fabry and HCM | Daniele Massera |
| What makes the Fabry heart tick? The role of inflammation in Cardiomyopathy | John Jefferies |
5:45 pm - 6:45 pm | Reception and Posters (reception is courtesy of Sanofi) | |